New hope for patients whose blood disorder Won't respond to standard pills
NCT ID NCT07206823
Summary
This study is testing whether combining two existing drugs can help adults with a rare blood disorder called immune thrombocytopenia (ITP) when standard oral medications have failed. All 30 participants will receive weekly infusions of one drug and weekly injections of another, with doses adjusted based on their blood platelet counts. The main goal is to see if this combination safely increases platelet levels and reduces bleeding over a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMACY IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.